A bias correction in testing treatment efficacy under informative dropout in clinical trials

Fanhui Kong1, Yeh-Fong Chen, Kun Jin

  • 1Division of Biometrics I, Food and Drug Administration, Silver Spring, Maryland 20993, USA. fanhui.kong@fda.hhs.gov

Insights

This study introduces a new grouping method to address informative patient dropout in clinical trials, improving treatment efficacy estimation. The method corrects biases caused by missing data, offering more stable and reliable inferences compared to traditional approaches.

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Longitudinal Data Analysis

Background:

  • Patient dropout is a significant source of missing data in clinical trials.
  • Informative patient dropout can introduce bias into treatment efficacy estimations.
  • Traditional methods like Observed Case (OC) and Last Observation Carried Forward (LOCF) may not adequately handle informative dropout.

Purpose of the Study:

  • To propose a novel grouping method for correcting bias in treatment effect estimation.
  • To address informative dropout schemes dependent on unobserved outcomes via random coefficients.
  • To provide an asymptotic variance estimator for statistical inference.

Main Methods:

  • Development of a grouping method for bias correction in time-saturated treatment effect models.
  • Incorporation of an informative dropout scheme dependent on random coefficients.
  • Derivation of an asymptotic variance estimator for robust statistical inference.

Main Results:

  • The proposed grouping method effectively corrects biases in treatment effect estimation.
  • The new method demonstrates improved stability and accuracy compared to OC, LOCF, and Mixed Model Repeated Measurement (MMRM) approaches.
  • Simulation studies confirm the superiority of the proposed method in handling informative dropout.

Conclusions:

  • The proposed grouping method offers a significant advancement in analyzing clinical trial data with informative patient dropout.
  • This approach enhances the reliability of treatment efficacy inferences, crucial for drug development.
  • The method provides a more stable and accurate alternative to existing statistical techniques for longitudinal data analysis.

Related Concept Videos

Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bias01:22

Bias

Bias refers to any tendency that prevents a question from being considered unprejudiced. In research, bias occurs when one outcome or answer is selected or encouraged over others in sampling or testing. Bias can occur during any research phase, including study design, data collection, analysis, and publication.
In statistics, a sampling bias is created when a sample is collected from a population, and some members of the population are not as likely to be chosen as others (remember, each member...
Censoring Survival Data01:09

Censoring Survival Data

Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different reasons...